Skip links

Reflections on being named Top in My Field

Jump To Section

It’s not often you get named as one of the top 50 marketers in the world, but I was recently voted by my peers to receive a OnCon Icon Award as a Top 50 Marketer at the OnCon 2020 conference.

Jeff Fleischman: Top 50 Marketer, OnCon Icon Award Winner, Altimetrik’s Global Impact

It’s not often you get named as one of the top 50 marketers in the world, but I was recently voted by my peers to receive a OnCon Icon Award as a Top 50 Marketer at the OnCon 2020 conference. Looking at the list of my fellow recipients, I can see that I, and Altimetrik, are in great company. I view this as recognition of the work that my global marketing team and I are doing to take Altimetrik to the next level.

Altimetrik is a great story and our work has resonated with clients. Their trust in us has fueled double-digit revenue growth year after year and helped us in surpassing 2,500 employees.

We are a pure-play digital business company, focused exclusively on helping some of the world’s biggest companies get unstuck in their transformation efforts.

Altimetrik: Client-Centric Transformation Fuel

There are a multitude of vendors that talk a good game about business transformation, so how do we differentiate ourselves? The best way is simply in the way we work with our clients. Rather than seeking to do everything all at once in a “big bang” approach, we partner with our clients to make incremental improvements that establish a track record of success and spark a cultural transformation that in turn drives transformation of the business.

In fact, many of our client relationships start with a proof of concept project approach. Once we demonstrate how our collaborative approach achieves success, we build a long-lasting partnership with that client.

Our job as marketers is to let the world know about our work, but that often bleeds into other disciplines. I thought the OnCon 2020 conference was interesting because it reinforced that trend. It was exclusive to senior-level executives, but instead of just focusing on marketing like so many other conferences, it offered three tracks – legal, marketing, human resources – to provide a cross-functional perspective on the issues that are taking place in today’s organizations.

OnCon 2020: Elevating CX for Business Success

I had an opportunity at the conference to lead a roundtable discussion on how good customer experience drives bottom line results. This has been a passion of mine for years. In a previous role, I championed the use of technology to transform the experience of buying life insurance, in one of the oldest and most tradition-bound of industries.

People can go anywhere to buy what they need these days – product features and functions are no longer a differentiator – and I have long held that a good customer experience will create a long-lasting and defensible differentiator.

Again, I’m thrilled to win this award, but I see it as a recognition of the efforts of all of us at Altimetrik. Building our brand reputation and how we help clients get unstuck in their transformation to deliver exceptional experiences is easier when you have a proven track record. I hope you follow along for more to come.

Jeff Fleischman

Jeff Fleischman

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes